/ Print /

  • linkedin
  • Increase Font
  • Sharebar

    Trump’s steps to undo the ACA: Top takeaways from healthcare insiders


    President Trump began the process of disassembling Obamacare by using the “power of the pen” to sign an executive order on healthcare, as well as taking a separate executive notice of intent to “prop up” what the White House calls a “broken system.”


    The executive order “seeks to facilitate the creation of national, association health plans and create small cap, short-term individual policies that would not be subject to current state or federal regulations,” says Jay Wolfson, DrPH, JD, distinguished service professor, Public Health, Medicine and Pharmacy, and senior associate dean, Morsani College of Medicine, University of South Florida Health.

    Trump also issued a notice of intent to immediately stop federal payments for cost-sharing reductions. “This order removes subsidies that [would be] paid to insurance companies by the ACA intended to stabilize rates—separate from subsidies paid directly to low-income beneficiaries,” Wolfson says.

    Between the executive order and ending cost-sharing reduction payments, the latter is much more impactful and destabilizing to the individual market, according to John Steele, managing partner at HealthScape. 


    “We will now see how the states and Congress respond,” he says. “Taken together, the executive order creates an avenue for non-subsidized purchasers to move to short-term or association plans. With many states allowing insurers to modify silver plan pricing with no cost-sharing reductions, we will see subsidized purchasers move to a bronze metal selection with many having a zero-premium bronze plan. Financially, we will likely see significant variation in risk adjustment transfers and profitability as the market adjusts. Without legislative or state-based actions, we will see a very different market in 2018.”

    Cost-sharing reductions: Impact on insurers

    The cost-sharing subsidies are needed to help stabilize the individual market, says Rosemarie Day, president of Day Health Strategies.

    “Without them, insurers will pull the trigger on prices that will no doubt be as much as 20% higher, which would create chaos, and particularly harm those people who don’t qualify for subsidies,” she says.  

    Wolfson agrees that stopping the payments will “directly threaten” the financial viability of ACA products.

    “While the ACA has been on a trajectory to implode because of flawed actuarial assumptions and design issues, this excision of federal subsidies to insurers will expedite that implosion process,” he says. “It will make the products even more expensive for those already unable to afford them—especially lower- and middle-income persons, and it will encourage even more financial services corporations to get out of the ACA business.” 

    As of Thursday evening, Acting HHS Secretary Eric Hargan and CMS Administrator Seema Verma stated that the payments would discontinue “immediately.”

    “This may be too late for many insurers who have already calculated premiums for 2018 to 2019, and for the November 2017 start of the new sign-up period for ACA subsidized policies,” says Wolfson. “But these pronouncements may be part of Trump’s hardline rhetorical strategy intended to advance ACA insecurity and force Democrats to the negotiating table.”

    Next: Impact on consumers



    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Follow Us On Twitter

    Find us on Facebook

    Latest Tweets Follow